KR101768843B1 - 주사가능 장기-작용 국소 마취제 반고체 제형 및 이의 조성물 - Google Patents

주사가능 장기-작용 국소 마취제 반고체 제형 및 이의 조성물 Download PDF

Info

Publication number
KR101768843B1
KR101768843B1 KR1020157026862A KR20157026862A KR101768843B1 KR 101768843 B1 KR101768843 B1 KR 101768843B1 KR 1020157026862 A KR1020157026862 A KR 1020157026862A KR 20157026862 A KR20157026862 A KR 20157026862A KR 101768843 B1 KR101768843 B1 KR 101768843B1
Authority
KR
South Korea
Prior art keywords
semi
solid
pharmaceutical composition
glyceride
fatty acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020157026862A
Other languages
English (en)
Korean (ko)
Other versions
KR20150126375A (ko
Inventor
후이 룽 선
나 간
Original Assignee
미라 파마 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 미라 파마 코포레이션 filed Critical 미라 파마 코포레이션
Publication of KR20150126375A publication Critical patent/KR20150126375A/ko
Application granted granted Critical
Publication of KR101768843B1 publication Critical patent/KR101768843B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020157026862A 2013-02-28 2014-02-28 주사가능 장기-작용 국소 마취제 반고체 제형 및 이의 조성물 Expired - Fee Related KR101768843B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361771011P 2013-02-28 2013-02-28
US61/771,011 2013-02-28
PCT/US2014/019704 WO2014134586A2 (en) 2013-02-28 2014-02-28 Injectable long-acting local anesthetic semi-solid formulations and its compostions

Publications (2)

Publication Number Publication Date
KR20150126375A KR20150126375A (ko) 2015-11-11
KR101768843B1 true KR101768843B1 (ko) 2017-08-17

Family

ID=50288331

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020157026862A Expired - Fee Related KR101768843B1 (ko) 2013-02-28 2014-02-28 주사가능 장기-작용 국소 마취제 반고체 제형 및 이의 조성물

Country Status (8)

Country Link
US (1) US10500281B2 (enExample)
EP (1) EP2961380B1 (enExample)
JP (1) JP6363115B2 (enExample)
KR (1) KR101768843B1 (enExample)
CN (1) CN105120839B (enExample)
AU (1) AU2014223993B2 (enExample)
CA (1) CA2903020C (enExample)
WO (1) WO2014134586A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9849180B2 (en) 2014-09-15 2017-12-26 Hui Rong Shen Long-acting semi-solid lipid formulations
EP2961380B1 (en) 2013-02-28 2020-04-08 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid formulations and its compositions
US10220093B2 (en) 2013-02-28 2019-03-05 Mira Pharma Corporation Long-acting semi-solid lipid formulations
US20170296484A1 (en) * 2015-11-23 2017-10-19 Grace Therapeutics Llc Topical Film-Forming Spray
EP3452119A1 (en) * 2016-05-02 2019-03-13 The General Hospital Corporation Implant surfaces for pain control
EP3558279A4 (en) * 2016-12-26 2020-12-02 Cellix Bio Private Limited COMPOSITIONS AND METHODS FOR THE TREATMENT OF CHRONIC PAIN
JP7046396B2 (ja) * 2017-12-06 2022-04-04 湖州惠中濟世生物科技有限公司 注射可能な長時間作用性局所麻酔薬半固形製剤
US10561606B2 (en) 2017-12-06 2020-02-18 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid gel formulations
US11426418B2 (en) 2017-12-06 2022-08-30 Mira Pharma Corporation Injectable long-acting semi-solid gel formulations
CN113262302B (zh) * 2020-02-17 2022-12-09 湖州惠中济世生物科技有限公司 可注射长效半固体凝胶制剂
EP4284272A4 (en) * 2021-01-29 2024-12-25 Insitu Biologics, Inc. COMPOSITIONS AND METHODS OF SUSTAINED TREATMENT OF PAIN
JP2023027715A (ja) * 2021-08-17 2023-03-02 株式会社カネカ 医薬組成物、及び貼付剤

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007066148A1 (en) * 2005-12-07 2007-06-14 Pharmakodex Ltd Transdermal administration of active agents , in particular diclofenac

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775659A (en) * 1985-08-19 1988-10-04 Eli Lilly And Company Injectable semi-solid formulations
SE9200952D0 (sv) 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical carrier system containing defined lipids
US5700485A (en) 1992-09-10 1997-12-23 Children's Medical Center Corporation Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid
JPH08143449A (ja) * 1994-11-17 1996-06-04 Lederle Japan Ltd 徐放性局所麻酔用注射剤
US6413536B1 (en) 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
CN1156961A (zh) 1995-06-09 1997-08-13 欧罗赛铁克股份有限公司 产生长效局部麻醉的制剂和方法
GB9610862D0 (en) * 1996-05-23 1996-07-31 Evans Brian K Pharmaceutical products
ES2373861T3 (es) 1997-09-18 2012-02-09 Pacira Pharmaceuticals, Inc. Composiciones anestésicas liposomiales de liberación sostenida.
AU781682B2 (en) * 2000-03-20 2005-06-09 Zoetis Services Llc Sustained-release compositions for parenteral administration
US6613355B2 (en) 2000-05-11 2003-09-02 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
GB0015617D0 (en) 2000-06-26 2000-08-16 Vectura Ltd Improved preparations for dermal delivery of active substances
DE10033059A1 (de) * 2000-07-07 2002-01-31 Wacker Chemie Gmbh Komplexe aus gamma-Cyclodextrin und Benzocain, Verfahren zu ihrer Herstellung und ihre Verwendung
DE10041478A1 (de) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
US20040001889A1 (en) * 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
US20070184089A1 (en) * 2002-07-15 2007-08-09 Alcon, Inc. Non-Polymeric Lipophilic Pharmaceutical Implant Compositions for Intraocular Use
US8221778B2 (en) 2005-01-12 2012-07-17 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
US7666914B2 (en) 2004-06-03 2010-02-23 Richlin David M Topical preparation and method for transdermal delivery and localization of therapeutic agents
PL3085363T3 (pl) 2007-03-28 2019-08-30 Innocoll Pharmaceuticals Limited Urządzenie dostarczające lek dla zapewnienia miejscowej analgezji, miejscowego znieczulenia lub blokady nerwowej
CN102458388B (zh) 2009-06-11 2016-09-28 光治疗Asa公司 半固体组合物及药物制品
WO2011075623A1 (en) 2009-12-18 2011-06-23 Latitude Pharmaceuticals, Inc. One - phase gel compos ition compri s ing phos pholi pids
SG184072A1 (en) * 2010-04-01 2012-10-30 Pharmanest Ab Bioadhesive compositions of local anaesthetics
WO2011121034A2 (en) * 2010-04-01 2011-10-06 Pharmanest Ab Water-free pharmaceutical compositions suitable for local anaesthetics
WO2011121074A1 (en) * 2010-04-01 2011-10-06 Pharmanest Ab Thermogelling anaesthetic compositions
EP2961380B1 (en) 2013-02-28 2020-04-08 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid formulations and its compositions
DK3134068T3 (da) 2014-04-21 2021-10-04 Heron Therapeutics Inc Langtidsvirkende polymerafgivelsessystemer

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007066148A1 (en) * 2005-12-07 2007-06-14 Pharmakodex Ltd Transdermal administration of active agents , in particular diclofenac

Also Published As

Publication number Publication date
EP2961380B1 (en) 2020-04-08
US10500281B2 (en) 2019-12-10
AU2014223993A1 (en) 2015-10-15
CN105120839A (zh) 2015-12-02
US20150366967A1 (en) 2015-12-24
JP2016510041A (ja) 2016-04-04
AU2014223993B2 (en) 2016-09-08
EP2961380A2 (en) 2016-01-06
WO2014134586A2 (en) 2014-09-04
CA2903020A1 (en) 2014-09-04
KR20150126375A (ko) 2015-11-11
JP6363115B2 (ja) 2018-07-25
CA2903020C (en) 2019-06-18
WO2014134586A3 (en) 2014-11-06
CN105120839B (zh) 2020-07-28

Similar Documents

Publication Publication Date Title
KR101768843B1 (ko) 주사가능 장기-작용 국소 마취제 반고체 제형 및 이의 조성물
KR101351771B1 (ko) 바람직하게 ｓａｉｂ와 같은 당 에스테르를 포함하는지속적인 국소 마취제 조성물
EP2244752B1 (en) Low viscosity liquid polymeric delivery system
JP2004511431A (ja) 生物活性物質を含む生分解性ビヒクルおよび送達システム
JP6417327B2 (ja) オピオイド製剤
US10561606B2 (en) Injectable long-acting local anesthetic semi-solid gel formulations
US10220093B2 (en) Long-acting semi-solid lipid formulations
JP7670390B2 (ja) 徐放性脂質前駆製剤
US11426418B2 (en) Injectable long-acting semi-solid gel formulations
EP3720420B1 (en) Injectable long-acting local anesthetic semi-solid gel formulations
CN113262302B (zh) 可注射长效半固体凝胶制剂
CN116669717A (zh) 长效原位成型/胶凝组合物
JP7767636B2 (ja) 疼痛治療用医薬組成物
US9849180B2 (en) Long-acting semi-solid lipid formulations
HK1150982B (en) Low viscosity liquid polymeric delivery system

Legal Events

Date Code Title Description
A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

D13-X000 Search requested

St.27 status event code: A-1-2-D10-D13-srh-X000

D14-X000 Search report completed

St.27 status event code: A-1-2-D10-D14-srh-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20220811

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20220811